"Willingness to accept collateral damage may seem chilling, but it has some historical precedent. The path of medical progress is strewn with cases of questionable ethics, desperate practices, and misguided experimentalism, if not outright exploitation. And since patients with the fewest options are invariable the ones most likely to try (or be forcibly volunteered for) risky new treatments ... they're also the ones who bear the brunt of medicine's experimental nature. "As many as half of all clinical trials are already conducted in locations far from the pharmaceutical companies' home base, in countries like India, China, and Brazil. ... Drug outsourcing is seen as the fast to economic and scientific growth - a money train that the country [India] can't afford to miss. ... India, the brilliant hub of outsourced labor, was positioning itself in a newly lucrative role - guinea pig to the world." Wired, 03/2006, p 145 ff "People Who experience mood swings, fear, voices and visions"